Mark Avagliano - Jul 5, 2024 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Signature
/s / Monica Roberts Thomas, attorney-in-fact
Stock symbol
GTHX
Transactions as of
Jul 5, 2024
Transactions value $
-$6,615
Form type
4
Date filed
7/8/2024, 05:55 PM
Previous filing
Jul 3, 2024
Next filing
Sep 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Sale -$6.62K -2.64K -1.08% $2.51 242K Jul 5, 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the Reporting Person.
F2 The price represents the weighted average price with a low of $2.47 and a high of $2.545. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Represents (i) 26,035 shares of common stock; (ii) 1,375 RSUs from award granted on January 4, 2021; (iii) 4,500 RSUs from award granted on January 3, 2022; (iv) 12,875 RSUs from award granted on January 3, 2023; (v) 17,500 RSUs from award granted on May 10, 2023; (vi) 44,760 RSUs from award granted on January 3, 2024; (vii) 100,000 RSUs from award granted on March 20, 2024; and (viii) 35,000 RSUs from award granted on July 1, 2024.